Westcot Ventures Corp. Announces Name Change to “WPD Pharmaceuticals Inc.” VANCOUVER, British Columbia, Jan. 14, 2020 (GLOBE NEWSWIRE) -- Westcot Ventures Corp (CSE: WBIO) (the “Company”), a clinical stage pharmaceutical company, announces that it has changed its name from...

WPD Pharmaceuticals’ New Discovery for Cancer Targeting Drugs is Granted Patent VANCOUVER, British Columbia, Jan. 09, 2020 (GLOBE NEWSWIRE) -- WPD Pharmaceuticals (CSE: WBIO) (the “Company” or “WPD”), a clinical stage pharmaceutical company, is pleased to announce that on...

WPD Pharmaceuticals Provides 2019 Corporate Year End Review VANCOUVER, British Columbia, Jan. 08, 2020 (GLOBE NEWSWIRE) -- Westcot Ventures Corp. (CSE: WBIO) (the “Company”), and its wholly-owned subsidiary WPD Pharmaceuticals sp. z.o.o (“WPD”), a clinical...

Westcot Ventures Corp. Announces Closing of Transaction of WPD Pharmaceuticals Sp. Z.o.o. NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Dec. 23, 2019 (GLOBE NEWSWIRE) -- Westcot Ventures Corp. (the “Company” or...